CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
eszopiclone +1 moredrug
Likely dose
eszopiclone 3 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00833547
NCT00833547N/ACompleted
CompareCT.gov

Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia

Massachusetts General Hospital·interventional·Posted Feb 2, 2009·Updated Sep 9, 2014

In Brief

A clinical study evaluating eszopiclone and placebo for Schizophrenia. Completed, enrolled 25 participants across 1 site.

Detailed Summary

This study will determine whether eszopiclone will normalize sleep patterns and restore sleep-dependent enhancement of motor skill learning in patients with schizophrenia. The investigators will compare subjects taking a placebo to those taking 3 mg of eszopiclone with regard to: sleep architecture and sleep latency as measured by actigraphy and polysomnography and sleep-dependent motor skill learning.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia
CountriesUnited States
CollaboratorsSumitomo Pharma America, Inc., Beth Israel Deaconess Medical Center

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 2, 2009
Enrollment StartSep 1, 2006
Primary CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 6 yearsPosted 17.4 years ago

Interventions

eszopiclonedrug

3 mg of eszopiclone at bedtime on two consecutive nights

placebodrug

Placebo capsules looking identical to eszopiclone at bedtime on two consecutive nights